journal article·2025-01-13

A New Type of Bioprosthetic Heart Valve: Synergistic Modification with Anticoagulant Polysaccharides and Anti-inflammatory Drugs

Xinyun Pu, Xu Peng, Shubin Shi, Shaoxiong Feng, Xu Wei, Xi Gao, Xixun Yu

Publisher page

Abstract

Valvular heart disease (VHD) poses a significant threat to human health, and the transcatheter heart valve replacement (THVR) is the best treatment for severe VHD. Currently, the glutaraldehyde cross-linked commercial bioprosthetic heart valves (BHVs) remain the first choice for THVR. However, the cross-linking by glutaraldehyde exhibits several drawbacks, including calcification, inflammatory reactions, and difficult endothelialization, which limits the longevity and applicability of BHVs. In this study, λ-carrageenan with anticoagulant function was modified by carboxymethylation into carboxymethyl λ-carrageenan (CM-λC); subsequently, CM-λC was used as a cross-linking agent to stabilize decellularized bovine pericardial tissue through amide bonds formed by a 1-(3-(Dimethylamino)propyl)-3-ethylcarbodiimide/ N -Hydroxysuccinimide (EDC/NHS)-catalyzed reaction between the amino functional groups within pericardium and the carboxyl group located on CM-λC. Lastly, the inclusion complex (CD/Rutin) (formed by encapsulating the rutin molecule through the hydrophobic cavity of the mono-(6-ethylenediamine-6-deoxy)-β-cyclodextrin) was immobilized onto above BHVs materials (λCar-BP) through the amidation reaction. The treated sample exhibited mechanical properties and collagen stability similar to those of GA-BP, except for improved flexibility. Because of the presence of sulfonic acid groups and absence of aldehyde group as well as the Rutin release from CD/Rutin immobilized onto BHVs, the hemocompatibility, anti-inflammatory, HUVEC-cytocompatibility, and anticalcification properties, of the CM-λC-fixed BP modified with CD/Rutin was significantly better than that of GA-BP. In summary, this nonaldehyde-based natural polysaccharide cross-linking strategy utilizing the combination of CM-λC and CD/Rutin provides a novel solution to obtain BHVs with durable and stable anticoagulant, anticalcification, and anti-inflammatory properties, and has a wide range of potential applications in improving the various properties of BHVs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Cardiac Valve Diseases and Treatments · Proteoglycans and glycosaminoglycans research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, P.R. China

Experimental and Research Animal Institute, Sichuan University, Chengdu 610041, P.R. China

Funding

Sichuan University · Chengdu Science and Technology Bureau · Key Research and Development Program of Sichuan Province

References (55)

Show source-provided references
1. 10.1038/s41569-021-00570-z10.1038/s41569-021-00570-z ↗
2. 10.1093/eurheartj/ehad12110.1093/eurheartj/ehad121 ↗
3. 10.1016/j.cej.2023.14504410.1016/j.cej.2023.145044 ↗
4. 10.1161/CIRCULATIONAHA.118.03718710.1161/CIRCULATIONAHA.118.037187 ↗
5. 10.1016/j.biomaterials.2023.12207010.1016/j.biomaterials.2023.122070 ↗
6. 10.1161/CIR.000000000000095010.1161/CIR.0000000000000950 ↗
7. 10.5402/2013/72879110.5402/2013/728791 ↗
8. 10.1039/D3TB01724A10.1039/D3TB01724A ↗
9. 10.1161/CIRCULATIONAHA.118.03735910.1161/CIRCULATIONAHA.118.037359 ↗
10. 10.1016/j.jacc.2016.11.08410.1016/j.jacc.2016.11.084 ↗
11. 10.1016/j.pcad.2020.04.00210.1016/j.pcad.2020.04.002 ↗
12. 10.1016/j.jcin.2020.03.05210.1016/j.jcin.2020.03.052 ↗
13. 10.3390/jcm1111309010.3390/jcm11113090 ↗
14. 10.1586/17434440.3.6.81710.1586/17434440.3.6.817 ↗
15. 10.1016/j.actbio.2023.09.04510.1016/j.actbio.2023.09.045 ↗
16. 10.1038/s41591-022-01682-w10.1038/s41591-022-01682-w ↗
17. 10.1111/aor.1371810.1111/aor.13718 ↗
18. 10.1016/j.jacc.2016.09.95810.1016/j.jacc.2016.09.958 ↗
19. 10.1016/S0140-6736(17)30764-X10.1016/S0140-6736(17)30764-X ↗
20. 10.1016/j.biomaterials.2006.02.00810.1016/j.biomaterials.2006.02.008 ↗
21. 10.1039/D2TB01826H10.1039/D2TB01826H ↗
22. 10.1016/S0142-9612(03)00204-710.1016/S0142-9612(03)00204-7 ↗
23. 10.1002/jbm.a.2012910.1002/jbm.a.20129 ↗
24. 10.1016/j.biomaterials.2003.09.10510.1016/j.biomaterials.2003.09.105 ↗
25. 10.1002/jbm.b.3150310.1002/jbm.b.31503 ↗
26. 10.1067/mtc.2001.11762410.1067/mtc.2001.117624 ↗
27. 10.1177/088532821143054210.1177/0885328211430542 ↗
28. 10.1097/MAT.0b013e31818f288010.1097/MAT.0b013e31818f2880 ↗
29. 10.1111/aor.1315110.1111/aor.13151 ↗
30. 10.1016/j.cej.2023.14535810.1016/j.cej.2023.145358 ↗
31. 10.1016/j.cej.2020.12824410.1016/j.cej.2020.128244 ↗
32. 10.1039/D1RA08982J10.1039/D1RA08982J ↗
33. 10.1021/acsabm.0c0055010.1021/acsabm.0c00550 ↗
34. 10.1126/sciadv.abm337810.1126/sciadv.abm3378 ↗
35. 10.1021/acs.macromol.2c0250110.1021/acs.macromol.2c02501 ↗
36. 10.1016/j.biopha.2009.03.00510.1016/j.biopha.2009.03.005 ↗
37. 10.1016/j.ijbiomac.2015.12.03210.1016/j.ijbiomac.2015.12.032 ↗
38. 10.1016/S0049-3848(00)00338-810.1016/S0049-3848(00)00338-8 ↗
39. 10.3390/polym1311174410.3390/polym13111744 ↗
40. 10.1016/j.ijbiomac.2023.12378710.1016/j.ijbiomac.2023.123787 ↗
41. 10.1016/j.jep.2013.10.03610.1016/j.jep.2013.10.036 ↗
42. 10.1016/j.biopha.2017.10.00110.1016/j.biopha.2017.10.001 ↗
43. 10.1016/j.biopha.2021.11186710.1016/j.biopha.2021.111867 ↗
44. 10.1039/D0FO02276D10.1039/D0FO02276D ↗
45. 10.1016/j.carbpol.2011.10.00910.1016/j.carbpol.2011.10.009 ↗
46. 10.1016/j.actbio.2023.09.04510.1016/j.actbio.2023.09.045 ↗
47. 10.3389/fbioe.2022.95726310.3389/fbioe.2022.957263 ↗
48. 10.1016/j.molstruc.2023.13516910.1016/j.molstruc.2023.135169 ↗
49. 10.1007/s10847-014-0396-410.1007/s10847-014-0396-4 ↗
50. 10.3390/polym1302024610.3390/polym13020246 ↗
51. 10.1016/j.molliq.2020.11430810.1016/j.molliq.2020.114308 ↗
52. 10.1161/CIRCULATIONAHA.105.54931110.1161/CIRCULATIONAHA.105.549311 ↗
53. 10.1016/j.msec.2016.11.13310.1016/j.msec.2016.11.133 ↗
54. 10.1007/s10856-020-06462-x10.1007/s10856-020-06462-x ↗
55. 10.1002/adhm.20170146110.1002/adhm.201701461 ↗